Theme 2: Impact and cost-effectiveness
Researchers in this theme will work closely alongside those in Theme 1 to generate evidence to improve the epidemiological understanding, assess risk, and inform vaccination guidance and policy. This can be achieved through integration of data relating to microbiology, immunology, spatiotemporal disease distribution, health economics, and social science. The GHRG-GI will build upon a strong track record of applied research and vaccine modelling in Malawi and share expertise and knowledge with Kenya and Ethiopia.
Our Team:
Please see below the contact information for those working in the 'Impact and cost- effectiveness' theme. For more information please click here.
Due to Theme 1 and Theme 2 being closely aligned researchers are working across both themes.